Clinical Decision Support Systems (CDSS) Market is Expected to Reach $2.5 billion | MarketsandMarkets

North America accounted for the largest share of the global clinical decision support systems followed by Europe, Asia Pacific, and Rest of the World.

Clinical Decision Support Systems (CDSS) market in terms of revenue was estimated to be worth $1.7 billion in 2023 and is poised to reach $2.5 billion by 2028, growing at a CAGR of 7.5% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. According to article published in StatPearls 2023, stated that in US 7,000 to 9,000 patients die annually because of medication errors. Integration of CDSS can support the improvement of medication safety and reduce medication-related expenditures and errors. This is possible due to the functionalities of CDSS solutions which includes computerized reminders and advice regarding drug selection, dosage, interactions, allergies, and the scheduling of subsequent orders. Additionally, the growth in this market is majorly driven by the implementation of new government regulations and initiatives to promote the adoption of HCIT solutions. However, high investment necessities for the implementation of clinical decision support systems (CDSS) are are expected to restrain market growth to a certain extent.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18085342

Clinical Decision Support Systems (CDSS) market major players covered in the report, such as:

• Wolters Kluwer N.V. (Netherlands)
• Oracle (US)
• Merative (US)
• Change Healthcare (US)
• Veradigm Inc. (US)
• athenahealth (US)
• Epic Systems Corporation (US)
• Elsevier B.V. (Netherlands)
• Zynx Health (US)
• Koninklijke Philips N.V. (Netherlands)
• Medical Information Technology, Inc. (US)
• NextGen Healthcare, Inc. (US)
• CureMD Healthcare (US)
• Siemens Healthineers (Germany)
• EBSCO Information Services (US)
• GE HealthCare (US)
• eClinicalWorks (US)
• The Medical Algorithms Company (UK)
• RAMPmedical (Germany)
• Hera-MI (France)
• CareCloud, Inc. (US)
• VisualDx (US)
• Premier, Inc. (US)
• First Databank, Inc. (US)
• Strata Decision Technology (US)
• and Among Others

Buy a Clinical Decision Support Systems (CDSS) Industry Report (232 Pages PDF with Insightful ChartsTables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=18085342

The study categorizes the clinical decision support systems market into the following segments and subsegments:By Product

• Integrated CDSS
• Standalone CDSS

By Delivery Mode

• On Premise Mode
• Cloud based Mode

By Model

• Knowledge based CDSS
• Non-Knowledge based CDSS

By Type

• Therapeutic CDSS
• Diagnostic CDSS

By Component

• Services
• Software
• Hardware

By Application

• Advanced CDSS
• Conventional CDSS

By Level of Interactivity Level

• Active CDSS
• Passive CDSS

By Setting

• In Patient
• Ambulatory care settings

By Region

• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe (RoE)
• Asia Pacific
• Japan
• China
• India
• Rest of APAC (RoAPAC)
• RoW
• Latin America
• Middle East and Africa

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=18085342

The key stakeholders in the Clinical Decision Support Systems (CDSS) market include:

• Senior Management
• Supply Chain Manager
• Research & Development Team
• Product Manager/Sales Manager
• Hospitals (public and private)
• Ambulatory surgical centers (ASCs)
• Surgeons, physicians, and operating room staff

Recent Developments:

• In April 2023, Microsoft (US) and Epic Systems Corporation (US) expanded their long-standing strategic collaboration to develop and integrate generative AI into healthcare by combining the scale and power of Azure OpenAI Service with Epic’s industry-leading electronic health record (EHR) software. This co-innovation is focused on delivering a comprehensive array of generative AI- powered solutions integrated with Epic’s EHR to increase productivity, enhance patient care, and improve financial integrity of health systems globally.
• In April 2023, Elsevier B.V. (UK) announced the launch of an upgraded version of its clinical decision support solution, ClinicalKey. This enhanced platform incorporates a comprehensive drug compendium, a cutting-edge mobile application, and seamless integration into Electronic Health Records (EHR). These new features have been strategically designed to offer physicians in the United States and international markets convenient access to reliable and extensive medical content directly at the point of care, speeding up diagnosis and treatment for their patients.
• In February 2023, The province of Nova Scotia, in collaboration with Nova Scotia Health Authority (NSHA) and IWK Health (IWK) entered into a new 10-year agreement has been signed with Oracle (US) to implement an integrated electronic care record across the province for the more than one million Nova Scotians. This technology can help improve the way health professionals use and share patient information.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=18085342

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/clinical-decision-support-systems-market-18085342.html